- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study of Personalized Neoantigen Specific TCR T cells in the Treatment of Advanced Solid Cancers
This study is looking at a new way to treat advanced cancers using your body's own immune cells. Doctors will take some of your special immune cells, teach them to fight your cancer, and then give them back to you. It's an early-stage study to see if it's safe and how it works.
Netherlands - recruitingPHASE1, PHASE2
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
This study looks at a new drug, BNT329, for people with advanced cancers that have a marker called CA19-9. We want to find out if it's safe, what the best dose is, and if it can help stop cancer growth.
United States · Germany · Spain